Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.650
-0.200 (-10.81%)
At close: Mar 28, 2025, 4:00 PM
1.690
+0.040 (2.42%)
Pre-market: Mar 31, 2025, 8:33 AM EDT
Annovis Bio Employees
As of December 31, 2023, Annovis Bio had 16 total employees, including 6 full-time and 10 part-time employees. The number of employees increased by 11 or 220.00% compared to the previous year.
Employees
16
Change (1Y)
11
Growth (1Y)
220.00%
Revenue / Employee
n/a
Profits / Employee
-$1,536,898
Market Cap
32.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANVS News
- 3 days ago - Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewsWire
- 6 days ago - Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program - GlobeNewsWire
- 9 days ago - Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results - GlobeNewsWire
- 20 days ago - Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment - GlobeNewsWire
- 5 weeks ago - Annovis to Host Patients' Live Forum on February 27, 2025 - GlobeNewsWire
- 7 weeks ago - Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 7 weeks ago - Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease - GlobeNewsWire
- 7 weeks ago - Annovis Bio, Inc. Announces Closing of $21 Million Public Offering - GlobeNewsWire